Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Net Cash Flow (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Net Cash Flow readings, the most recent being $2.4 million for Q1 2026.

  • On a quarterly basis, Net Cash Flow rose 324.96% to $2.4 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$1.6 million, a 271.53% decrease, with the full-year FY2025 number at -$3.4 million, up 6.24% from a year prior.
  • Net Cash Flow hit $2.4 million in Q1 2026 for Pharma-Bio Serv, up from -$586201.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $7.6 million in Q4 2023 to a low of -$7.3 million in Q1 2023.
  • Median Net Cash Flow over the past 5 years was $245575.0 (2022), compared with a mean of -$691748.4.
  • The widest YoY moves for Net Cash Flow: up 3008.91% in 2023, down 577.36% in 2023.
  • Pharma-Bio Serv's Net Cash Flow stood at $245575.0 in 2022, then soared by 3008.91% to $7.6 million in 2023, then crashed by 96.73% to $249957.0 in 2024, then plummeted by 334.52% to -$586201.0 in 2025, then soared by 505.14% to $2.4 million in 2026.
  • The last three reported values for Net Cash Flow were $2.4 million (Q1 2026), -$586201.0 (Q4 2025), and $1.9 million (Q3 2025) per Business Quant data.